Durvalumab (Ingredient)
Drugbank ID: DB11714
The information below refers to products available in the United States that contain durvalumab.
Products containing durvalumab
durvalumab systemic
Brand name: Imfinzi
Drug class: anti-PD-1 and PD-L1 monoclonal antibodies (immune checkpoint inhibitors)
Durvalumab systemic is used in the treatment of:
- Biliary Tract Tumor
- Endometrial Cancer
- Hepatocellular Carcinoma
- Non Small Cell Lung Cancer
- Small Cell Lung Cancer
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
